Pending

Association of complement C3d receptor 2 genotypes with the acquisition of HIV infection in a trial of recombinant glycoprotein 120 vaccine.
Use of a Modified Classic BT Shunt in a Patient With Multiple Conduit Obstructions With Positive Lupus Anticoagulant.
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE.
Lupus versus dermatomyositis: the hands say it all.
Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
Mathematical processing is affected by daily but not cumulative glucocorticoid dose in patients with systemic lupus erythematosus.
Pentraxin 3: A promising therapeutic target for autoimmune diseases.
Numbness and Weakness in a Patient With Systemic Lupus Erythematosus.
SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression.
Vogt-Koyanagi-Harada Disease and Systemic Lupus Erythematosus Occurring during Adalimumab Therapy for Ulcerative Colitis.
Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic.
Transcatheter Aortic Valve Implantation in Patients with Connective Tissue Disease.
Emerging B-Cell Therapies in Systemic Lupus Erythematosus.
Stage one adenocarcinoma of uterine cervix in a patient with systemic lupus erythematosus – a clinical case.
From TTP to Glomerulonephritis: A Lifetime of Lupus.
Raised Plasma Levels of Asymmetric Dimethylarginine Are Associated with Pathological Type and Predict the Therapeutic Effect in Lupus Nephritis Patients Treated with Cyclophosphamide.
Tofacitinib-induced subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis.
Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion.
Remission in SLE-do DORIS criteria match the treating physician’s judgment? A cross sectional study to assess reasons for discordance.
Algorithm for calculating high disease activity in SLE.
Genome-wide association study on Northern Chinese identifies KLF2, DOT1L and STAB2 associated with systemic lupus erythematosus.
Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy.
Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial.
Lupus erythematosus: Significance of dermatologic findings.
Subacute cutaneous lupus erythematosus induced by PD-1 Inhibitor therapy: two case reports and literature review.
Longitudinally Extensive Transverse Myelitis in a Lupus-Neuromyelitis Optica Overlap.
Tubercular meningitis in patients with systemic lupus erythematosus: clinical characteristics, risk factors, and outcomes of 10 patients.
Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics.
Tuberculous arthritis of the ankle joint masquerading as rheumatoid arthritis in a patient with lupus nephritis.
PREVALENCE OF THE ABCB1-1Δ GENE IN NONDOMESTIC SPECIES OF THE CANIDAE FAMILY.
Membranous nephropathy: current understanding of various causes in light of new target antigens.
Artemisinin analogue SM934 protects against lupus-associated antiphospholipid syndrome via activation of Nrf2 and its targets.
Cryopreservation of Grey Wolf (Canis lupus) Testicular Tissue.
Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus Erythematosus
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
Negative Pressure Wound Therapy With Instillation and Dwell Time Used to Treat Pyoderma Gangrenosum: A Case Report.
Risk Factors for Short-Term Complication After Open Reduction and Internal Fixation of Ankle Fractures: Analysis of a Large Insurance Claims Database.
Juvenile-onset multifocal osteonecrosis in systemic lupus erythematosus: A case report.
Successful treatment of subdural hemorrhage and retinal hemorrhage in childhood-onset systemic lupus erythematosus associated with thrombocytopenia: Case report.
Dihydroartemisinin attenuated the symptoms of mice model of systemic lupus erythematosus by restoring the Treg/Th17 balance.
Mitral Valve Mass in a Patient Suspected of Systemic Lupus: Tumor, Endocarditis or Both?
Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
Neonatal lupus erythematosus – practical guidelines.
Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry.
Persistent deficiency of mucosal-associated invariant T cells during dermatomyositis.
Young-Onset Ischemic Colitis: A Condition of Elusive Etiology Frequently Associated With Immune Dysregulation.
Clinical characteristics of systemic lupus erythematosus with chylothorax and/or chylous ascites: An analysis of 15 cases in China.
Subacute cutaneous lupus erythematosus in a patient with Sjögren’s syndrome taking terbinafine for onychomycosis.
Maternal and Fetal Outcomes in Systemic Lupus Erythematosus Pregnancies.
Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.
Alkaline-Encrusted Pyelitis Causing Renal Failure in a Transplant Kidney: Treatment with Percutaneous Nephrolithotomy and Urinary Acidification.
Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus.
Rituximab – The first twenty years.
When POTS is the tip of the iceberg: Rare cases of dysautonomia as a possible manifestation of another disorder.
Concomitant Diagnosis of Fibromyalgia and Ankylosing Spondylitis: Relation to Clinical Features and Plasma Pentraxin -3 Level.
Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE.
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’.
Clinical improvement of cardiac function in a patient with systemic lupus erythematosus and heart failure with preserved ejection fraction treated with belimumab.
The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.
Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?
Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal.
MAIT cells, their biological and medical significance.
Network pharmacology modeling identifies synergistic interaction of therapeutic and toxicological mechanisms for Tripterygium hypoglaucum Hutch.
The Main Challenges in Systemic Lupus Erythematosus: Where Do We Stand?
Concentrated autologous bone marrow aspirate transplantation versus conservative treatment for corticosteroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.
Lupus podocytopathy: a newly emerging nonimmune complex mediated nephropathy associated with systemic lupus erythematosus.
Clinical practice guidelines and recommendations for the management of patients with systemic lupus erythematosus: a critical comparison.
Cytomegalovirus in Indian systemic lupus erythematosus patients: troublemaker or onlooker?
Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies.
Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia.
Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases.
Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: Weighting the risk of infection and flare.
How a discerning cytological examination can aid in the diagnosis of infectious diseases: case reports.
Efficacy of Fractional Er:YAG Laser in Lupus Erythematosus Scars
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus.
Tumoral calcinosis in systemic lupus erythematosus associated with fat necrosis.
[Clinical Features and Risk Factors of Systemic Lupus Erythematosus Complicated with Cytomegalovirus Infection].
Childhood granulomatous periorificial dermatitis: case report and review of the literature.
The role of Stim1 in the progression of lupus nephritis in mice.
New findings associated with presumptive systemic lupus erythematosus in a kitten.
Porphyria cutanea tarda exacerbation as a paraneoplastic syndrome in vaginal cancer resolved with chemoradiation.
Prevalence of osteoporosis in patients with systemic lupus erythematosus: A multicenter comparative study of the World Health Organization and fracture risk assessment tool criteria.
Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
[Toxic hydroxychloroquine-induced cardiomyopathy complicating systemic lupus treatment].
The impact of autoimmune systemic inflammation and associated medications on male reproductive health in patients with chronic rheumatological, dermatological, and gastroenterological diseases: A systematic review.
Electron microscopy study of 496 cases of lupus nephritis: A single-center experience.
A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient.
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK.
How do systemic lupus erythematosus patients with very-long disease duration present? Analysis of a monocentric cohort.
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine.
RITUXILUP Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
Risk factors associated with adverse pregnancy outcomes in patients with new-onset systemic lupus erythematosus during pregnancy.
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.
Immune responses to azacytidine in animal models of inflammatory disorders: a systematic review.
Transplantation-mediated alloimmune thrombocytopenia successfully treated by retransplantation.
Successful treatment of severe interstitial pneumonia by removal of circulating autoantibodies: a case series.
Shrinking lung syndrome treated with rituximab in pediatric systemic lupus erythematosus: a case report and review of the literature.
Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.

Interleukin-22 and connective tissue diseases: emerging role in pathogenesis and therapy.
Current status of use of high throughput nucleotide sequencing in rheumatology.
Systemic Lupus Erythematosus: Perinatal Outcomes in Patients Treated With and Without Hydroxychloroquine.
Inhibition of B cell activation following in vivo co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice.
Interferon-directed therapies for the treatment of systemic lupus erythematosus: a critical update.
COVID-19, rheumatic diseases and immune dysregulation-a perspective.
The Roles of Orphan G Protein-Coupled Receptors in Autoimmune Diseases.
Consequences of insurance denials among U.S. patients prescribed repository corticotropin injection (Acthar® Gel) for nephrotic syndrome.
Impact of Antimalarial Adherence on Mortality among Patients with Newly Diagnosed Systemic Lupus Erythematosus: A Population-based Cohort Study.
The complex relationship between C4b Binding Protein, warfarin and antiphospholipid antibodies.
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
Low ambient temperature increases hospital re-admissions for systemic lupus erythematosus in humid subtropical region: a time series study.
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients.
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.
D-mannose ameliorates autoimmune phenotypes in mouse models of lupus.
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis.
Higher Hydroxychloroquine Blood Levels Are Associated with Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting.
Refractory palmo-plantar Discoid Lupus Erythematosus successfully treated with Mycophenolate Mofetil: unusual localization and literature review.
Total plaque area and plaque echogenicity are novel measures of subclinical atherosclerosis in patients with systemic lupus erythematosus.
Anti-NuMA antibodies: clinical associations and significance in patients with primary Sjögren’s syndrome or systemic lupus erythematosus.
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week long therapy in patients with SLE.
Ileocolic intussusception caused by mass-forming fibro-granulation from healed ulcer masquerading as small bowel lipoma.
[Advances in induction therapy drugs of lupus nephritis for children].
Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood.
Patient and parent perspectives on transition from paediatric to adult healthcare in rheumatic diseases: an interview study.
Immune Cell-Stromal Circuitry in Lupus Photosensitivity.
[Change of diagnosis and diagnostic category in patients with juvenile idiopathic arthritis within 7 years of follow-up].
Modular gene analysis reveals distinct molecular signatures for cutaneous lupus patient subsets.
B cell depletion in murine lupus using cytotoxic T lymphocytes in vivo: Feasibility and benefit.
B7-H3: A promising therapeutic target for autoimmune diseases.
Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-β-Dependent Mechanism.
Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
Hydroxychloroquine and maintenance immunosuppression use in kidney transplant recipients: Analysis of linked US registry and claims data.
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
The Effect of Mycophenolate Mofetil as First-Line Therapy on the Timing of Urine Protein-to-Creatinine Ratio Reduction in Immunosuppressant-Naive Patients With Lupus Nephritis at a Single Center.
Immunotherapies application in active stage of systemic lupus erythematosus in pregnancy: A case report and review of literature.
Clinical Images: Hydroxychloroquine-associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus.
Predicting lupus flares: epidemiological and disease related risk factors.
The latest in systemic lupus erythematosus-accelerated atherosclerosis: related mechanisms inform assessment and therapy.
Cellular aspects of the pathogenesis of lupus nephritis.
Mobile health technologies for the management of rheumatic diseases: a systematic review of online stores in Brazil.
COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases.
Rosai-Dorfman-Destombes Disease as First Manifestation of Systemic Lupus Erythematosus.
Spermatic vein thrombosis with lupus anticoagulant, a cause of acute inguinal pain: a case report.
Hemocoagulative post-operative changes after laparoscopic surgery compared to open surgery: the role of lupus anticoagulant.
Anti-neutrophil properties of natural gingerols in models of lupus.
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
National Analysis of Coronary Artery Bypass Grafting in Autoimmune Connective Tissue Disease.
Economic Evaluation of Damage Accrual in an International Systemic Lupus Erythematosus Inception Cohort Using a Multistate Model Approach.
Discovery of BIIB068: A Selective, Potent, Reversible Bruton’s Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.
COVID-19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration.
A Peculiar Case of Small Bowel Stricture in a Coronavirus Disease 2019 Patient with Congenital Adhesion Band and Superior Mesenteric Vein Thrombosis.
Innovative use of concentrated growth factors combined with corticosteroids to treat discoid lupus erythematosus alopecia: A case report.
From incomplete to complete systemic lupus erythematosus; A review of the predictive serological immune markers.
Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
Corticosteroid dosing and opioid use are high in patients with SLE and remain elevated after belimumab initiation: a retrospective claims database analysis.
IL-23/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis.
Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway.
Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management.
Computational Studies of Hydroxychloroquine and Chloroquine Metabolites as Possible Candidates for Coronavirus (COVID-19) Treatment.
Resorption of immune deposits in membranous lupus nephritis following rituximab vs conventional immunosuppressive treatment.
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders.
Predictors of unsuccessful hydroxychloroquine tapering and discontinuation: Can we personalize decision-making in systemic lupus treatment?
Beta Cell Function is Disrupted in Patients with Systemic Lupus Erythematosus.
Discovery of BMS-986202: A Clinical Tyk2 Inhibitor that Binds to Tyk2 JH2.
Thymoquinone in autoimmune diseases: Therapeutic potential and molecular mechanisms.
Evaluation of corneal safety in systemic lupus erythematosus patients undergoing long-term hydroxychloroquine treatment.
Total Glucosides of Peony Protect Cardiomyocytes against Oxidative Stress and Inflammation by Reversing Mitochondrial Dynamics and Bioenergetics.
Clinical Observation of COVID-19 in a Patient With an Acquired Humoral Deficiency Secondary to Chemotherapeutic Agents.
COVID-19 in children treated with immunosuppressive medication for kidney diseases.
Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
Antithyroid Drug-Induced Lupus Erythematosus and Immunoglobulin A Deficiency.
Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform.
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
Safety, Tolerability, and Pharmacokinetics of PF-06823859, an Anti-Interferon β Monoclonal Antibody: A Randomized, Phase I, Single- and Multiple-Ascending-Dose Study.
Oxidative stress-induced aberrant lipid metabolism is an important causal factor for dysfunction of immunocytes from patients with systemic lupus erythematosus.
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Belimumab in lupus nephritis.
Linear cutaneous lupus erythematosus in children-report of two cases and review of the literature: A case report.
Understanding patient-provider discordance in adolescents with lupus: The role of pain and antidepressant medication use.
The Effect of Biological Agents on Antinuclear Antibody Status in Patients with Psoriasis: A Single-Center Study.
Secondary Membranous Nephropathy. A Narrative Review.
Childhood Systemic Lupus Erythematosus; a Rare Multisystem Disorder: Case Report of a 3-year-old Girl with Oral Involvement as a Primary Sign.
Successful hydroxychloroquine treatment in a patient with systemic lupus erythematosus-associated nailfold capillary abnormalities.
Systemic lupus erythematosus symptom clusters and their association with patient-reported outcomes and treatment: Analysis of real-world data.
STING-dependent induction of lipid peroxidation mediates intestinal ischemia-reperfusion injury.
De novo lupus nephritis during treatment with belimumab.
Bilateral ear lobe infiltration: an unusual presentation of lupus vulgaris.
Erratum to 16th international congress on antiphospholipid antibodies task force report on antiphospholipid syndrome treatment trends.
Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and Chloroquine.
Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.
Basophils and IgE contribute to Mixed Connective Tissue Disease development.
Lung Cancer Immunotherapy in Transplant Patients and in Patients With Autoimmune Diseases.
CD95/Fas and metastatic disease: What does not kill you makes you stronger.
Kikuchi-Fujimoto disease preceded by lupus erythematosus panniculitis: do these findings together herald the onset of systemic lupus erythematosus?
CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
Glomerular Disease and Pregnancy.
Discovery of M5049: A Novel Selective TLR7/8 Inhibitor for Treatment of Autoimmunity.

VDAC1 in the diseased myocardium and the effect of VDAC1-interacting compound on atrial fibrosis induced by hyperaldosteronism.
Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, Function.
Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells.
IL-Y Aggravates Murine Chronic Graft-Versus-Host Disease by Enhancing T and B Cell Responses.
New therapeutic approaches in systemic lupus erythematosus.
B cell activating factor (BAFF): Structure, functions, autoimmunity and clinical implications in Systemic Lupus Erythematosus (SLE).
Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
Xanthogranulomatous pleuritis – An unusual presentation of tuberculosis.
Monitoring of anticoagulation in thrombotic antiphospholipid syndrome.
Cryptococcemia According to Immune Status: An Analysis of 65 Critical Cases.
Hepatocellular adenoma(s) arising in nodular regenerative hyperplasia in a patient with systemic lupus erythematosus.
Coxiella burnetii Endocarditis in a Patient with Systemic Lupus Erythematosus: A Case Report of a Diagnostic Challenge.
Neutrophil Activation and Neutrophil Extracellular Trap Formation in Dialysis Patients.
Comparison of effectiveness of topical Tacrolimus 0.1% vs topical Halobetasol Propionate 0.05% as an add-on to oral Hydroxychloroquine in Discoid Lupus Erythematosus.
The place of sphingosine-1-phosphate modulators in the therapy of inflammatory bowel diseases
Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study.
Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.
Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
Effects and interferences of emicizumab, a humanized bispecific antibody mimicking activated factor VIII cofactor function, on lupus anticoagulant assays.
Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice.
Risk of herpes zoster in the Japanese population with immunocompromising and chronic disease conditions: Results from a claims database cohort study, from 2005 to 2014.
Primary Sjögren’s Syndrome and Cardiovascular Disease.
Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single center experience.
Patient-Reported Lupus Flare Symptoms Are Associated with Worsened Patient Outcomes and Increased Economic Burden.
What is the appropriate anticoagulation strategy for thrombotic antiphospholipid syndrome?
Extraction of DNA from plastinated tissues.
Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases.
Peripheral B Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies.
Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases.
Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
Lupus nephritis-related issues during COVID-19 pandemic quarantine.
Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A1 in patients with lupus nephritis.
Tocilizumab and its usage for skin diseases.
Analysis of Trans-Ancestral SLE Risk Loci Identifies Unique Biologic Networks and Drug Targets in African and European Ancestries.
Lung Cancer Survival in Patients With Autoimmune Disease.
Reduction in SLEDAI is associated with improved arterial stiffness in systemic lupus erythematosus.
CD62L on blood basophils: a first pre-treatment predictor of remission in severe lupus nephritis.
Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: A population-based cohort study.
Improving eye screening practice among pediatric rheumatology patients receiving hydroxychloroquine.
Systemic lupus erythematosus-related acute pancreatitis.
Systemic lupus erythematosus: The search for the ideal biomarker.
Advances in Microbiome Detection Technologies and Application in Antirheumatic Drug Design.
Genetic variant CFH rs6677604 might play a protective role in lupus nephritis.
Predictors of renal damage in systemic lupus erythematous patients: data from a multiethnic, multinational Latin American lupus cohort (GLADEL).
Simultaneous Presentation of Parvovirus B19 Infection and Systemic Lupus Erythematosus in a Patient: Description and Review of the Literature.
Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study.
A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
The role of neuraminidase in TLR4-MAPK signaling and the release of cytokines by lupus serum-stimulated mesangial cells.
Myocardial Infarction in Systemic Lupus Erythematosus – the Sex Specific Risk Profile.
Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice.
Systemic erythematous lupus after treatment of multiple sclerosis with alemtuzumab.
Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
Non-infective supraglottitis: two cases of unusual aetiology.
Ovarian antibodies among SLE women with premature menopause after cyclophosphamide.
Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis.
A glance upon Epigenetic and COVID-19.
Cutaneous Kikuchi disease-like inflammatory pattern without lymph node involvement is associated with systemic disease and severe features in lupus erythematous: A case-control study.
BTK inhibition modulates multiple immune cell populations involved in the pathogenesis of immune mediated nephritis.
Clinical Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
Anti-CD20 monoclonal antibodies in Systemic Lupus Erythematosus.
Common causes of hair loss – clinical manifestations, trichoscopy and therapy.
Regulatory effect of glutathione on treg/Th17 cell balance in allergic rhinitis patients through inhibiting intracellular autophagy.
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs.
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors.
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
Treatment targets in SLE: remission and low disease activity state.
The patient’s perspective: are quality of life and disease burden a possible treatment target in systemic lupus erythematosus?
Treatment of severe thrombocytopenia associated with systemic lupus erythematosus in pregnancy with eltrombopag: A case report and literature review.
Long-term remission in patients with systemic lupus erythematosus.
The Type II anti-CD20 Antibody Obinutuzumab (GA101) is More Effective than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus Model.
Intestinal Pseudo-Obstruction as the Initial Clinical Presentation in Systemic Lupus Erythematosus: A Rare and Severe Disorder.
Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome.
Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs).
Successful treatment by mycophenolate mofetil of subacute progressive interstitial lung disease associated with systemic lupus erythematosus.
A woman with systemic lupus erythematosus, multiple pregnancy complications, and cerebral infarction who was only positive for phosphatidylserine-dependent antiprothrombin antibodies.
Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study.
Evans’ Syndrome: From Diagnosis to Treatment.
What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus.
Sodium Butyrate Ameliorates Gut Microbiota Dysbiosis in Lupus-Like Mice.
Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.
Platelet proteome changes in dogs with congestive heart failure.
IgA autoantibodies directed against self DNA are elevated in cystic fibrosis and associated with more severe lung dysfunction.
Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
Tuberculosis in patients with systemic lupus erythematosus: a 37-year longitudinal survey-based study.
Clinical features and outcomes from the Singapore Sjögren’s syndrome study.
Study of M5049 in Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) Participants
Low-dose 17α-ethinyl estradiol (EE) exposure exacerbates lupus renal disease and modulates immune responses to TLR7/9 agonists in genetically autoimmune-prone mice.
Small molecule inhibition of human cGAS reduces total cGAMP output and cytokine expression in cells.
A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre.
Bach2 overexpression represses Th9 cell differentiation by suppressing IRF4 expression in systemic lupus erythematosus.
Diffuse Alveolar Haemorrhage in Systemic Lupus Erythematosus Patients.
Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey.
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.
Response to: ‘Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian et al’ by Notz et al.
Gut Microbiota and Bacterial DNA Suppress Autoimmunity by Stimulating Regulatory B Cells in a Murine Model of Lupus.
Releasing the brakes: a case report of pulmonary arterial hypertension induced by immune checkpoint inhibitor therapy.

BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid.
Necrotizing lymphadenitis : A case report and literature review.
Pharmacoeconomic Review Report: Belimumab (Benlysta): (GlaxoSmithKline Inc.): Indication: Indicated in addition to standard therapy for reducing disease activity in adult patients with active, autoantibody-positive systemic lupus erythematosus
Macrophage activation syndrome in a patient with systemic lupus erythematosus (SLE) and dual viremia.
Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report.
Q-fever prosthetic valve endocarditis in a patient with SLE and antiphospholipid antibody syndrome.
Employing a latent variable framework to improve efficiency in composite endpoint analysis.
Retinal and choroidal thickness changes in systemic lupus erythematosus patients: a longitudinal study.
Systemic lupus erythematosus, antiphospholipid syndrome and Hashimoto thyroiditis occurring in a patient with Niemann-Pick disease: a second case.
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE.
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstoma.
Investigating lupus retention in care to inform interventions for disparities reduction: an observational cohort study.
Systemic lupus erythematosus gastrointestinal involvement: a computed tomography-based assessment.
Lupus Nephritis and Chronic Kidney Disease.
Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice.
A Study to Assess the Safety and Tolerability, PK and Efficacy of KPG-818 in Mild to Moderate SLE Patients
Anti-tumor necrosis factor (TNF)-induced lupus in a patient with hidradenitis suppurativa.
Case Series of Chronic Inflammatory Rheumatic Disease Patients Infected by Coronavirus Disease 2019 (COVID-19).
Clinical Outcomes of Hip Arthroscopy in Patients With Systemic Inflammatory Diseases Compared With Matched Controls at a Minimum of 2-Year Follow-Up.
Severe mitral valve regurgitation secondary to Libman-Sacks endocarditis.
A case of acute myelogenous leukemia characterized by arterial and venous thrombosis.
Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus.
Anti-Tyro3 IgG Associates with Disease Activity and Reduces Efferocytosis of Macrophages in New-Onset Systemic Lupus Erythematosus.
Lupus Anticoagulant in Patients with Covid-19. Reply.
Long-term safety and efficacy of anifrolumab in adults with systemic lupus erythematosus: results of a phase 2 open-label extension study.
A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
Impact of systemic factors in shaping the periodontal microbiome.
NCS 613, a PDE4 inhibitor, by increasing cAMP level suppresses systemic inflammation and immune complexes deposition in kidney of MRL/lpr lupus- prone mice.
Belimumab in Lupus Nephritis: New Trial Results Arrive During an Exciting Time for Therapeutics.
Long-term efficacy and safety outcomes of lenalidomide for cutaneous lupus erythematosus: a multicenter retrospective observational study of 40 patients.
Fracture risk in systemic lupus erythematosus patients over 28 years.
Hemolytic Disease of the Fetus and Newborn Caused by Maternal Autoantibody with Mimicking Anti-E Specificity.
Plaque-like Cutaneous Lupus Mucinosis as the First Sign of Systemic Lupus Erythematosus.
Towards a practical management of fatigue in systemic lupus erythematosus.
Anifrolumab for the treatment of active systemic lupus erythematosus: a meta-analysis of randomized controlled trials.
The use of anti-TNF-alpha therapies for patients with Systemic Lupus Erythematosus. Where are we now?
Pulmonary hypertension in connective tissue diseases, new evidence and challenges.
Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature.
Late-onset systemic lupus erythematosus: characteristics and outcome in comparison to juvenile- and adult-onset patients-a multicenter retrospective cohort.
Isoradiotopic response of discoid lupus after radiotherapy: A case report and review of the literature.
Cryptococcal meningitis in patients with lupus nephritis.
Neutrophil Extracellular Traps in Autoimmunity and Allergy: Immune Complexes at Work.
Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis.
Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus.
The spectrum of lupus myocarditis: from asymptomatic forms to cardiogenic shock.
Multi-pronged approach to enhance education of children and adolescents with lupus, caregivers, and healthcare providers in New Jersey: Needs assessment, evaluation, and development of educational materials.
[AN UNUSUAL DIAGNOSIS OF CHRONIC URTICARIA].
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review.
Atrial thrombus as a complication of SLE and APS in an 8-year-old child.
Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study.
A Case of Prolonged Catatonia Caused by Sjögren’s Syndrome.
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®.
Calcified constrictive pericarditis resulting in tamponade in a patient with systemic lupus erythematosus.
Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.
Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide.
Allergic diseases and long-term risk of autoimmune disorders: longitudinal cohort study and cluster analysis.
[Pyoderma gangrenosum and systemic lupus erythematosus: A rare association].
Systemic Lupus Erythematosus.
Pulmonary hypertension associated with congenital heart block and neonatal lupus syndrome: A series of four cases.
Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis.
Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
Time-Dependent Changes in Porcelain Aorta and Aortic Stenosis in a Patient with Systemic Lupus Erythematosus.
A case report of hydroxychloroquine-induced auditory and visual hallucination.
Successful Treatment of Urticarial Vasculitis in a Patient With Systemic Lupus Erythematosus With Rituximab.
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry.
Autoimmunity in Segmental Vitiligo.
COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics.
Fractalkine mediates lymphocyte inflammation and tubulointerstitial lesions by modifying the Treg/Th17 balance in lupus-prone MRL/lpr mice.
Rare Association of Antiphospholipid Antibody Syndrome, Systemic Lupus Erythematosus and Aortic Dissection: A Striking Presentation with Multi-Organ Failure?
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies.
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice.
Application of procalcitonin, white blood cell count and neutrophil-to-lymphocyte ratio in the diagnosis of systemic lupus erythematosus with a bacterial infection.
Experimental Study of Nanostructured Lipid Carrier in the Treatment of Immune Lupus Nephritis.
Effects of Nano-α-Linolenic Acid and miR-146 on Mice with Viral Myocarditis.
B-cell depletion or belimumab or voclosporin for lupus nephritis?
A Proposed Aeromedical Disposition Flowchart for Systemic Lupus Erythematosus.
Associations of metabolic syndrome in SLE.
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.
Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.
Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
Prevalence and associated factors of medication nonadherence among Thai patients with systemic lupus erythematosus.
Serum and Urine Monocyte Chemoattractant Protein-1 as A Markers for Lupus Nephritis.
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring.
Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.
Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Corticosteroid associated lupus pancreatitis.
Infusion of anti-DFS70 antibodies prolonged survival of lupus-prone mice.
Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils.
Outcome and Prognosis of Patients With Lupus Nephritis Submitted to Renal Transplantation.
Galectin-3 orchestrates the histology of mesentery and protects liver during lupus-like syndrome induced by pristane.
Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond.
Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa.
Transplant outcomes in kidney recipients with lupus nephritis, and systematic review.
Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance.
Systemic lupus erythematosus with autoimmune neurological manifestations in a carrier of chronic granulomatous disease – a rare presentation.
Acquired hemophilia A in a woman with systemic lupus erythematosus: A case report and review of literature.

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis.
Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
Emerging Technologies to Target Drug Delivery to the Skin – the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone.
Alternative complement pathway activation in thrombotic microangiopathy associated with lupus nephritis.
“Coronavirus could kill me #StayHomeSaveLives”: A content and sentiment analysis of tweets by people with arthritis during COVID-19.
Acute parkinsonism in patients with systemic lupus erythematosus: A case report and review of the literature.
Adverse drug reactions associated with treatment in patients with chronic rheumatic diseases in childhood: a retrospective real life review of a single center cohort.
Cardiac adverse events associated with chloroquine and hydroxychloroquine exposure in 20 years of drug safety surveillance reports.
Dorsolateral medullary infarction during skin infection by Stenotrophomonas maltophilia in a patient with triple antiphospholipid antibody positivity: a case-based review.
Neuronal surface P antigen (NSPA) modulates postsynaptic NMDAR stability through ubiquitination of tyrosine phosphatase PTPMEG.
Neurosurgical and neuro-immunological management of IgG4-related hypertrophic sclerosing pachymeningitis. A literature survey and discussion of a unique index case.
Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.
Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family.
Osteonecrosis of the distal tibia in systemic lupus erythematosus: A rare case report.
Efficacy and safety of rituximab for systemic lupus erythematosus treatment: a meta-analysis.
Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review.
Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE).
A Rare Case with Systemic Lupus Erythematosus Manifested by two Different Neurologic Entities; Guillain Barre Syndrome and Posterior Reversible Encephalopathy Syndrome.
Thromboendarterectomy in a patient with Systemic Lupus and antiphospholipid Syndrome, lessons learned from a complex disease interaction.
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients.
Refractory Urticaria with Raised Antistreptolysin O (ASO) Titer: An Intriguing Case of Adult-Onset Still’s Disease.
Rheumatologists’ perspective on hydroxychloroquine guidelines.
Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI).
The HSP90 Inhibitor, 17-AAG, Influences the Activation and Proliferation of T Lymphocytes via AKT/GSK3β Signaling in MRL/lpr Mice.
Concomitant onset of systemic lupus erythematosus and disseminated histoplasmosis: a case-based review.
Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.
Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis.
An unusual case of acute lower gastrointestinal bleeding due to fungal infection.
A Case of Systemic Lupus Erythematosus with Malignant Pleural Mesothelioma in a 42-year Woman.
Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, sham-controlled pilot trial.
Diffuse alveolar hemorrhage, a rare presentation of polymyositis.
Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug.
Complement C4A Regulates Autoreactive B Cells in Murine Lupus.
Update on Lupus Nephritis: Looking for a New Vision.
Lupus-like Disease in FcγRIIB-/- Mice Induces Osteopenia.
[Secondary ITP in adults].
[Cytomegalovirus infection in systemic lupus erythematosus patients. A series of 12 case reports and literature review].
Efficacy and safety of rituximab biosimilar in refractory lupus.
Belimumab in the treatment of Portuguese Systemic Lupus Erythematosus patients: a real-life multicenter study.
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.
Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus: a case-based review.
Twelve-Week Internet-Based Individualized Exercise Program in Adults With Systemic Lupus Erythematosus: Protocol for a Randomized Controlled Trial.
Lupus myocarditis in an octogenarian patient-a case report.
Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa.
Parvovirus B19 infection mimicking systemic lupus erythematosus, successfully treated with intravenous immune globulin.
Targeted delivery of immunosuppressant in SLE.
[The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases].
Effect of omega-3 fatty acids on systemic lupus erythematosus disease activity: A systematic review and meta-analysis.
Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.
Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study.
Endothelial dysfunction and cardiovascular risk in lupus nephritis: new roles for old players?
Cucurbitacin IIb improved active chromatin-induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells.
Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus.
Silica Exposure Differentially Modulates Autoimmunity in Lupus Strains and Autoantibody Transgenic Mice.
Nephritic Syndrome.
Association of AIRE (rs2075876), but not CTLA4 (rs231775) polymorphisms with Systemic Lupus Erythematosus.
TNIP1/ABIN1 and lupus nephritis: review.
Emicizumab-Induced Seronegative Full-House Lupus Nephritis in a Child.
Talaromyces marneffei Infection in Systemic Lupus Erythematosus Patients: Report of Two Cases and Review of the Literature.
Omega-3 Docosahexaenoic Acid (DHA) Impedes Silica-Induced Macrophage Corpse Accumulation by Attenuating Cell Death and Potentiating Efferocytosis.
A Comprehensive Review of Biological Agents for Lupus: Beyond Single Target.
Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis.
Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis.
Lupus and NMOSD: The Blending of Humoral Autoimmunity.
Identification of Long Noncoding RNAs lnc-DC in Plasma as a New Biomarker for Primary Sjögren’s Syndrome.
The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns.
Uric acid as a risk factor for progression to chronic kidney disease in patients with lupus nephritis: results from the KORNET registry.
The gut microbiota of non-treated patients with SLE defines an autoimmunogenic and proinflammatory profile.
A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus.
Milk fat globule epidermal growth factor 8 (MFG-E8) on monocytes is a novel biomarker of disease activity in systemic lupus erythematosus.
Predictors of the start of declining eGFR in patients with systemic lupus erythematosus.
Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study.
Discovery of Small Molecule Drugs Targeting the Biogenesis of microRNA-155 for the Treatment of Systemic Lupus Erythematosus.
Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Acute Kidney Injury Caused by Evans Syndrome with Systemic Lupus Erythematosus and Systemic Sclerosis.
Autoimmune Hypophysitis With Systemic Lupus Erythematosus: A Case Report and Literature Review.
SLE: Novel Postulates for Therapeutic Options.
T Cells in Autoimmunity-Associated Cardiovascular Diseases.
Application of LC-MS/MS method for determination of dihydroartemisin in human plasma in a pharmacokinetic study.
Impact of autoimmune cytopenias on severity of childhood-onset systemic lupus erythematosus: A single-center retrospective cohort study.
Atherosclerotic plaque vulnerability is increased in mouse model of lupus.
Clinical profile of osteonecrosis in systemic lupus erythematosus – Experience from a tertiary care centre in South India.
Assessing outcomes in a lupus nephritis cohort over a 40-year period.
Successful treatment of erythematous-squamous disorders of the external auditory canal with tacrolimus and clotrimazole in otic oil: our experience in 25 patients.
Treating Systemic Lupus Erythematosus (SLE): The Impact of Historical Environmental Context on Healthcare Perceptions and Decision-Making in Charleston, South Carolina.
Taxing the brain: a case of neuropsychiatric systemic lupus erythematosus.
Multifactorial aggressive and reversible cardiomyopathy in systemic lupus erythematosus.
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult Population.
Lupus-like nephritis with positive anti-neutrophil cytoplasmic antibodies and negative antinuclear antibodies.
The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients.
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus Erythematosus.
Associated clinical factors for serious infections in patients with systemic lupus erythematosus.
Hyaluronic Acid Synthesis Contributes to Tissue Damage in Systemic Lupus Erythematosus.
Trends of Hospital Palliative Care Utilization and Its Associated Factors Among Patients With Systemic Lupus Erythematosus in the United States From 2005 to 2014.
Dialysis in Pregnancy: Role of the Underlying Cause of Renal Failure on Peripartum Outcomes.
Digital Therapeutic Platform for Management of Systemic Lupus Erythematosus.
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Type 1 Interferon Gene Signature Promotes RBC Alloimmunization in a Lupus Mouse Model.

Lupus Vulgaris and Lichen Scrofulosorum with Disseminated Tuberculosis.
Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus.
Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients.
Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases.
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation.
A case of γδ T-cell large granular lymphocytic leukemia due to a chronic active Epstein-Barr virus infection in systemic lupus erythematosus.
Nine-test panel has superior sensitivity to detect antiphospholipid antibody syndrome in patients with or without SLE.
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations.
In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.
Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials.
Immunomodulatory effects of cytokine-induced expansion of cytotoxic lymphocytes in a mouse model of lupus-like disease.
Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases.
Renal Infiltration as a Primary Presentation of Burkitt Lymphoma Secondary to Systemic Lupus Erythematosus: A Rarity Unto a Rarity.
Case study of tacrolimus as an effective treatment for idiopathic membranous glomerulonephritis in pregnancy.
What about glucocorticoids in primary Sjögren’s syndrome?
A case of systemic sclerosis/lupus overlap syndrome presenting with bilateral cotton wool spots.
Recurrent Stevens-Johnson syndrome in a patient with systemic lupus erythematosus: a case report.
A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids.
Atypical femoral fracture associated with delayed union for which the cessation of alendronate and daily administration of teriparatide contributed to fracture healing: histopathological evidence of the enhancement in bone formation parameters.
Autoimmune myelofibrosis associated with systemic lupus erythematosus: a case report.
Concurrent onset of acute lupus myocarditis, pulmonary arterial hypertension and digital gangrene in a lupus patient: a possible role of vasculitis to the rare disorders.
Treatment of psoriatic arthritis complicated by systemic lupus erythematosus with the IL-17 blocker secukinumab and an analysis of the serum cytokine profile.
Clinical presentation of a neuropsychiatric lupus patient with symmetrical basal ganglia lesions containing cytotoxic oedema cores surrounded by vasogenic oedema.
Multifocal osteoarticular tuberculosis in a systemic lupus erythematosus (SLE) patient: a rarity or an underdiagnosed condition?
Successful treatment of refractory acute lupus haemophagocytic syndrome using rituximab: a case report.
Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report.
Why thromboembolism occurs in some patients with thrombocytopenia and treatment strategies.
The Investigation of the Association of Cutaneous Leishmaniasis in Biopsy Specimens of the Patients with Granulomatous Disease and Skin Cancer Using the Molecular Method.
Value of Urinary Neutrophil Gelatinase-Associated Lipocalin versus Conventional Biomarkers in Predicting Response to Treatment of Active Lupus Nephritis.
STING Mediates Lupus via the Activation of Conventional Dendritic Cell Maturation and Plasmacytoid Dendritic Cell Differentiation.
Prophylactic inhibition of soluble epoxide hydrolase delays onset of nephritis and ameliorates kidney damage in NZB/W F1 mice.
A case of chronic sarcoidosis presenting with lupus pernio.
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.
Next stop in the treatment of refractory systemic lupus erythematosus: B-cell targeted combined therapy.
Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus.
Candidate drug replacements for quinacrine in cutaneous lupus erythematosus.
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis.
Diagnoses, Outcomes, and Chronicity Predictors of Patients with Secondary Immune Thrombocytopenia: Ten-Year Data from a Hematology Referral Center.
Pharmacokinetics and Pharmacodynamics of JNJ-55920839, an Antibody Targeting Interferon α/ω, in Healthy Subjects and Subjects with Mild-to-Moderate Systemic Lupus Erythematosus.
Anti-IFNαR Mabs for the treatment of Systemic Lupus Erythematosus.
The TLC-NOSF (Technology Lipido-Colloid Plus Nano-Oligo Saccharide Factor) protease inhibitor for the treatment of ulceration in rheumatic disease A case report.
MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
Complement Inhibitors in Clinical Trials for Glomerular Diseases.
Antiphospholipid syndrome and infertility.
Choroidal thickness in lupus nephritis.
Septicaemia is associated with increased disease activity and mortality in systemic lupus erythematosus: a retrospective analysis from Taiwan.
COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case-report.
Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial.
IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis.
Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands.
Psychotherapy for the Treatment of Acute Musculoskeletal Pain: A Review of Clinical Effectiveness and Guidelines
Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians.
The Emerging Role of Renal Tubular Epithelial Cells in the Immunological Pathophysiology of Lupus Nephritis.
Sustained Remission of Lupus Panniculitis Treated With Hydroxychloroquine in a Patient With Crohn’s Disease: A Case Report.
Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia.
Antiphospholipid syndrome.
Update οn the diagnosis and management of systemic lupus erythematosus.
Comparative analysis of long-term organ damage in patients with systemic lupus erythematosus using belimumab versus standard therapy: a post hoc longitudinal study.
Articular involvement, steroid treatment and fibromyalgia are the main determinants of patient-physician discordance in systemic lupus erythematosus.
Kidney transplantation in systemic lupus erythematosus: Outcomes and prognosis.
EULAR recommendations for a core data set for pregnancy registries in rheumatology.
Evaluating cutaneous lupus disease activity end points and their effects on quality of life as an outcome measure for clinical trials.
Clinical management of Lupus patients during the COVID-19 pandemic.
Radiotherapy for Cervical Cancer in Patients with Systemic Lupus Erythematosus.
Development and exacerbation of pulmonary nontuberculous mycobacterial infection in patients with systemic autoimmune rheumatic diseases.
Complement Activation on Endothelial Cell-Derived Microparticles-A Key Determinant for Cardiovascular Risk in Patients with Systemic Lupus Erythematosus?
Clinical characteristics and prognosis of concomitant systemic lupus erythematosus and primary biliary cholangitis.
A simple and highly efficient method of IFI44L methylation detection for the diagnosis of systemic lupus erythematosus.
Pilocarpine for Sjögren’s Syndrome-Induced Dry Mouth and Dry Eyes: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.
A Histologic Analysis of a Retrieved Specimen 24 Years after Hemiresurfacing for Avascular Necrosis.
Serum adiponectin levels are associated with presence of carotid plaque in women with systemic lupus erythematosus.
Leveraging Heterogeneity in Systemic Lupus Erythematosus for New Therapies.
Peculiar blood flow profiles among placental chorionic villous vessels of an abnormally thick placenta in a case of systemic lupus erythematosus characterized using microvascular imaging.
Early damage as measured by SLICC/ACR damage index is a predictor of hospitalization in systemic lupus erythematosus (SLE).
Natural history of nonbacterial thrombotic endocarditis treated with warfarin.
The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis.
Centrally Acting Angiotensin-Converting Enzyme Inhibitor Suppresses Type I Interferon Responses and Decreases Inflammation in the Periphery and the CNS in Lupus-Prone Mice.
Niclosamide ethanolamine attenuates systemic lupus erythematosus and lupus nephritis in MRL/lpr mice.
Central Nervous System Vasculitis Secondary to Sarcoidosis: A Rare Case of Lupus Pernio With Complete Occlusion of Right Internal Carotid Artery.
Spectrum of autoimmune bullous diseases among children in Kuwait.
Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis.
Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase.
Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocytes-mediated Bullous Skin Disorders.
Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Coronary Artery Bypass Grafting in Patients with Systemic Lupus Erythematosus.
Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing.
Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways.
Src Family Protein Kinase Controls the Fate of B Cells in Autoimmune Diseases.
Systemic lupus erythematosus (SLE): emerging therapeutic targets.
Unexpectedly, low hydroxychloroquine concentration enhances DNA-induced immune stimulation in vitro: potential implication in non-compliant patients with SLE.
Methotrexate-induced toxic epidermal necrolysis in a child undergoing a combination therapy for systemic lupus erythematosus: a rare case report.
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
Causes, Risk Factors, and Clinical Outcomes of Stroke in Korean Young Adults: Systemic Lupus Erythematosus is Associated with Unfavorable Outcomes.
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina.
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum.
Correspondence on ‘Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis’.
Response to: ‘Correspondence on ‘Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis” by Xu.
24-hour Activity and Sleep Profiles for Adults Living with Arthritis: Habits Matter.

Comorbidity and health care utilisation in persons with Sjögren’s syndrome: a claims data analysis.
Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies.
Thrombophilia testing in patients with portal vein thrombosis.
No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
Chinese herbal compound prescription for systemic lupus erythematosus: A protocol for systematic review and meta-analysis.
A BAYESIAN ADAPTIVE TWO-STAGE DESIGN FOR PEDIATRIC CLINICAL TRIALS.
Refractory liver dysfunction was remarkably improved with chelating agents of Wilson’s disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection.
Factors Related to Knowledge, Perception, and Practices Towards COVID-19 Among Patients with Autoimmune Diseases: A Multicenter Online Survey.
Neuropsychiatric systemic lupus erythematosus with cerebellar vasculitis and obstructive hydrocephalus requiring decompressive craniectomy.
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
Development of Chronic Cutaneous Lupus Erythematosus During Biologic Therapy: A Systematic Review.
Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.
Salmonella enterica Subspecies arizonae Detected from Bilateral Pleural Fluid in a Patient with Systemic Lupus Erythematosus and Malignant Lymphoma.
Cytomegalovirus-induced cutaneous ulcer mimicking vasculitis in a patient with systemic lupus erythematous: A case report and review of the literature.
Clinical Characteristics, Management Practices, and In-hospital Outcomes among Trauma Patients with Venous Thromboembolism.
B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis.
Fecal Metabolites Were Altered, Identified as Biomarkers and Correlated With Disease Activity in Patients With Systemic Lupus Erythematosus in a GC-MS-Based Metabolomics Study.
Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells.
A case of hyperpigmentation induced by hydroxychloroquine and quinacrine in a patient with systemic lupus erythematosus and review of the literature.
Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus.
Dermatologic Applications and Safety Considerations of Janus Kinase Inhibitors.
Airways therapy of obstructive sleep apnea dramatically improves aberrant levels of soluble cytokines involved in autoimmune disease.
[Immune disorders associated with juvenile recurrent chronic parotitis].
Response to ustekinumab treatment in patients with systemic lupus erythematosus is linked to suppression of serum interferon gamma levels.
Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.
Innate immune response in systemic autoimmune diseases: a potential target of therapy.
The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Brief Report: Hydroxychloroquine does not induce hemolytic anemia or organ damage in a “humanized” G6PD A- mouse model.
Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.
Bone marrow transplantation from a human leukocyte antigen-mismatched unrelated donor in a case with C1q deficiency associated with refractory systemic lupus erythematosus.
PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
Biologics in the treatment of Sjogren’s syndrome, systemic lupus erythematosus, and lupus nephritis.
Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient: From the National Multiple Sclerosis Society Case Conference Proceedings.
Proteomic Analyses of Endarterectomized Tissues from Patients with Chronic Thromboembolic Pulmonary Hypertension.
Ovoid palatal patch: a clue to anti-TIF1γ dermatomyositis.
Blocking IL-17: A Promising Strategy in the Treatment of Systemic Rheumatic Diseases.
Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients.
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Protective effect of tolvaptan against cyclophosphamide-induced nephrotoxicity in rat models.
Secondary angle-closure glaucoma as an ocular presentation of systemic lupus erythematosus: a case report.
Identifying clinically meaningful severity categories for PROMIS pediatric measures of anxiety, mobility, fatigue, and depressive symptoms in juvenile idiopathic arthritis and childhood-onset systemic lupus erythematosus.
The effect of parity, history of preeclampsia, and pregnancy care on the incidence of subsequent preeclampsia in multiparous women with SLE.
Knowledge and attitudes about influenza vaccination in rheumatic diseases patients.
Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options.
Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
Dexamethasone Prodrug Nanomedicine (ZSJ-0228) Treatment Significantly Reduces Lupus Nephritis in Mice without Measurable Side Effects – A 5-Month Study.
Increasing Ancestral Diversity in Lupus Trials: Ways Forward.
Successful treatment of HIV-associated lupus-like glomerulonephritis with mycophenolic acid.
Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study.
Prevalence, predictors and prognostic benefits of remission achievement in patients with systemic lupus erythematosus: a systematic review.
Complication of Mycobacterium tuberculosis treatment: Isoniazid-induced pneumonitis.
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic Leukemia.
The role of TASL in the pathogenesis of SLE: X marks the spot.
SARS-CoV-2 Infection and COVID-19 in 5 Patients in Ecuador After Prior Treatment with Hydroxychloroquine for Systemic Lupus Erythematosus.
The C-C Chemokine Receptor Type 4 Is an Immunomodulatory Target of Hydroxychloroquine.
Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis.
Gilbert syndrome with systemic lupus erythematosus presenting with persistent unconjugated hyperbilirubinemia: A case report.
Cellulitis with Pseudomonas putida bacteremia in a patient with systemic lupus erythematosus: A case report.
Predictive factors of the lupus nephritis in a Tunisian cohort.
High prevalence of acquired thrombophilia without prognosis value in Covid-19 patients.
Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
A case of eosinophilic fasciitis without skin manifestations: a case report in a patient with lupus and literature review.
Analysis of time course and dose effect of tacrolimus on proteinuria in lupus nephritis patients.
Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances.
Response to: “A combination of complement activation products with autoantibodies predicts transition of probable lupus to systemic lupus erythematosus”.
Identifying novel B-cell targets for chronic inflammatory autoimmune disease by screening of chemical probes in a patient-derived cell assay.
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Sources of Pathogenic Nucleic Acids in Systemic Lupus Erythematosus.
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans.
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Rowell’s syndrome: a rare but distinct entity in rheumatology.
StatPearls
StatPearls
Dirofilaria immitis in wolves recolonizing northern Italy: are wolves competent hosts?
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reports.
Correction: Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
Images in Vascular Medicine. Marjolin’s ulcer with concurrent systemic lupus and venous disease.
Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis.
Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.
Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
Invasive maxillary aspergillosis in a patient with systemic lupus erythematosus: Case report.
Expressions of IFN-γ and IL-4 before and after Treatment of Lupus Nephritis with Traditional Chinese Medicine Combined with Cyclophosphamide and Their Values for Efficacy Prediction and Evaluation.
Bortezomib at therapeutic doses poorly passes the blood-brain barrier and does not impair cognition.
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort.
Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
Renal amyloidosis in a patient with systemic lupus erythematosus.
Long-Term Outcomes of Renal Transplant in Patients With End-Stage Renal Failure Due to Systemic Lupus Erythematosus and Granulomatosis With Polyangiitis.
COVID-19 Pandemic – A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
Facial erythema after the treatment of dupilumab in SLE patient.
Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
Evaluation of the inhibitory effect of tacrolimus combined with mycophenolate mofetil on mesangial cell proliferation based on the cell cycle.
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
De novo subacute cutaneous lupus erythematosus like eruptions in the setting of PD-1 or PD-L1 inhibitor therapy: clinical-pathological correlation.
Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion.
The NADase enzyme CD38: an emerging pharmacological target for systemic sclerosis, systemic lupus erythematosus and rheumatoid arthritis.
Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
Hydroxychloroquine and coronavirus disease 19.

Cerebral Microhemorrhage and Purpuric Rash in COVID-19: The Case for a Secondary Microangiopathy.
A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.
PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature.
Post-procedural Bacillus cereus septic arthritis in a patient with systemic lupus erythematosus.
Chloroquine to fight COVID-19: A consideration of mechanisms and adverse effects?
The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus.
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Belimumab as Add-on Therapy in Lupus Nephritis.
Medical conditions, pregnancy perspectives and contraceptive decision-making among young people: an exploratory, qualitative analysis.
An objective method of diagnosing hydroxychloroquine maculopathy.
Extracellular vesicles in Inflammatory Skin Disorders: from Pathophysiology to Treatment.
Antiphospholipid Antibodies Are Not Associated with Clinical Parameters or Prognostic Outcomes in Patients with Non-Hodgkin’s Lymphoma.
Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.
Management of cardiovascular disease in patients with systemic lupus erythematosus.
Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients.
Probable Autoimmune Depression in a Patient With Multiple Sclerosis and Antineuronal Antibodies.
Unilateral facial erythematous patch as the presenting sign of systemic lupus erythematosus.
Genotype-Guided Hydralazine Therapy.
B cells polarize pathogenic inflammatory T helper subsets through ICOSL-dependent glycolysis.
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus.
Mild Clinical Course of COVID-19 in 3 Patients Receiving Therapeutic Monoclonal Antibodies Targeting C5 Complement for Hematologic Disorders.
IL-17 sustains the plasma cell response via p38-mediated Bcl-xL RNA stability in lupus pathogenesis.
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
COPA syndrome, 5 years after: where are we?
Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus.
[Antiphospholipid syndrome : Update on diagnostics and management].
Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report.
Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.
Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis.
Autoantibody-dependent amplification of inflammation in SLE.
Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus.
Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus.
Efficacy and safety of sirolimus in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
New biomarkers in SLE: from bench to bedside.
The BAFF / APRIL system as therapeutic target in multiple sclerosis.
Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis.
Snare salvage technique for deformed WEB device after deployment.
Pregnancy in systemic lupus erythematosus.
Immunomodulatory Drugs in the Management of SARS-CoV-2.
Bilateral simultaneous Central Retinal Artery Occlusion (CRAO) in a patient with Systemic Lupus Erythematosus (SLE).
Serum IgG2 levels predict long-term protection following pneumococcal vaccination in systemic lupus erythematosus (SLE).
Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre.
Epilepsy in systemic lupus erythematosus.
Inhibition of IRF5 hyper-activation protects from lupus onset and severity.
Terbinafine-induced lichenoid drug eruption: case report and review of terbinafine-associated cutaneous adverse events.
How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
Extracellular vesicles and lupus nephritis – New insights into pathophysiology and clinical implications.
Infection-related glomerulonephritis mimicking lupus nephritis.
Incidence, Clinical Features, and Outcomes of Late-onset Neutropenia from Rituximab for Autoimmune Disease.
Biologic therapies for systemic lupus erythematosus: where are we now?
Update on antimalarials and systemic lupus erythematosus.
Sixteenth international congress on antiphospholipid antibodies task force. Report on obstetric antiphospholipid syndrome.
Catch the rainbow: Prognostic factor of sarcoidosis.
New insights into the role of antinuclear antibodies in systemic lupus erythematosus.
Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19.
The Association Between Oral Health and Skin Disease.
A Study on the Relevance of Glucose-6-Phosphate Dehydrogenase Level Screening in Patients with Rheumatic Diseases Prior to Initiating Treatment With Hydroxychloroquine.
Systemic lupus erythematosus presenting as thrombotic thrombocytopaenic purpura in a child: a diagnostic challenge.
Clinical analysis of 4 cases of Wernekink commissure syndrome.
Stercoral Perforation of Sigmoid Colon in Systemic Lupus Erythematosus: A Rare Cause of Peritonitis.
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis.
Mycophenolate mofetil in the treatment of Chinese patients with lupus nephritis: A PRISMA-compliant meta-analysis.
Primary breast diffuse large B-cell lymphoma in a patient with systemic lupus erythematosus: A case report and review of the literature.
TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases.
Study protocol for the international Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS): understanding lupus and the role of type I interferon gene signature.
Rituximab in Treatment of Children with Refractory Vasculitis and Systemic Lupus Erythematosus – Single Center Experience in Croatia.
[Autoimmune hemolytic anemias].
[Hip osteonecrosis].
Basic immunology may lead to translational therapeutic rationale: SARS-CoV-2 and rheumatic diseases.
A 31-Year-Old Man with COVID-19-Associated Empyema and Lupus Anticoagulant.
Complement Properdin Determines Disease Activity in MRL/lpr Mice.
Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Treatment.
Steroid treatment promotes an M2 anti-inflammatory macrophage phenotype in childhood lupus nephritis.
Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment.
Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis.
Establishing Consensus Understanding of the Barriers to Drug Development in Lupus.
Case report: a 10-year-old girl with primary hypoparathyroidism and systemic lupus erythematosus.
Increased levels of plasma nucleotides in patients with rheumatoid arthritis.
Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrospective study.
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’ by Mathian et al.
Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19’ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France.
Pharmacokinetics and pharmacodynamics of cenerimod, a selective S1P1 R modulator, are not affected by ethnicity in healthy Asian and Caucasian subjects.
Physical activity, sedentary behaviour and their associations with cardiovascular risk in systemic lupus erythematosus.
Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate.
The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology.
Mycophenolic acid area under the concentration-time curve is associated with therapeutic response in childhood-onset lupus nephritis.
Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview.
Cast-like calcification in the superior vena cava in a young woman with lupus nephritis on hemodialysis.
Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice.
Lupus Nephritis: Breaking the Lull.
Lupus Nephritis: How Far Have We Come, and Where Are We Headed?
Lupus Nephritis and Kidney Transplantation: Where Are We Today?
Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice.
[Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
An Update on the Pathogenesis of Cutaneous Lupus Erythematosus and Its Role in Clinical Practice.
Lupus Vasculitis.
Tripterygium and its plant extraction for systemic lupus erythematosus: A protocol for systematic review and meta analysis.
The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.

Association of microRNA 17 host gene variant (rs4284505) with susceptibility and severity of systemic lupus erythematosus.
Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
Severe systemic lupus erythematosus flare after abatacept treatment.
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine.
The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine.
Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues.
Hydroxychloroquine is protective to the heart, not Harmful: A systematic review.
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.
Systemic Lupus Erythematosus: Targeted literature review of the epidemiology, current treatment and disease burden in the Asia Pacific region.
COVID-19 versus HIT hypercoagulability.
Stereochemical Differences in Fluorocyclopropyl Amides Enable Tuning of Btk Inhibition and Off-Target Activity.
The first case of natalizumab-induced subacute cutaenous lupus erythematosus.
[Update on treatments and innovations in systemic auto-immune diseases].
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review.
EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.
Refractory lupus panniculitis treated successfully with rituximab: Two cases.
An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis.
Cutaneous squamous cell carcinoma as a complication of discoid lupus erythematosus.
Volunteer based approach to dog vaccination campaigns to eliminate human rabies: Lessons from Laikipia County, Kenya.
Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
Anifrolumab, a Monoclonal Antibody to the Type I Interferon Receptor Subunit 1, for the Treatment of Systemic Lupus Erythematosus: An Overview From Clinical Trials.
Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
Lower CH50 as a predictor for intractable or recurrent lupus enteritis: A retrospective observational study.
An unusual neurological presentation: systemic lupus erythematosus mimicking central nervous system infection.
Bio-inspired adhesive porous particles with human MSCs encapsulation for systemic lupus erythematosus treatment.
Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.
Accelerated, severe lupus nephritis benefits from treatment with honokiol by immunoregulation and differentially regulating NF-κB/NLRP3 inflammasome and sirtuin 1/autophagy axis.
Cytomegalovirus preventive strategies in lupus nephritis and renal vasculitis treated with immunosuppressants.
Type B insulin resistance syndrome: a systematic review.
Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change.
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
Urinary C3d is elevated in patients with active Lupus nephritis and a fall in its level after 3 months predicts response at 6 months on follow up.
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
Belimumab, a useful alternative therapy in systemic lupus erythematosus serositis.
Microarray-based transcriptional profiling of a mouse model of autoimmune hepatitis.
Urinary soluble CD163 is a good biomarker for renal disease activity in lupus nephritis.
Orbital myositis in systemic lupus erythematosus: A case report and literature review.
A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases.
Recombinant Zoster Vaccine in Stable SLE Patients
Cervical Cancer Screening in Women with Systemic Lupus Erythematosus.
Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study.
[Hydroxychloroquine treatment rarely causes eye damage when used correctly].
CircZNF609 is involved in the pathogenesis of focal segmental glomerulosclerosis by sponging miR-615-5p.
Fertility preservation in women for medical and social reasons: Oocytes vs ovarian tissue.
Arterial Hypertension in Systemic Lupus Erythematosus: About 40 Cases.
Macrophage activation syndrome triggered by active systemic lupus erythematosus : Successful treatment by interleukin-1 inhibition (anakinra).
Treatment of Cutaneous Lupus Erythematosus With 1064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Verses Topical Corticosteroid Alone.
Biologic Therapy in Refractory Non-Multiple Sclerosis Optic Neuritis Isolated or Associated to Immune-Mediated Inflammatory Diseases. A Multicenter Study.
Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
Lupus low disease activity (SLE) in patients treated with belimumab: a single-center real-life experience (2016-2019).
Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.
Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina.
Vertical gaze palsy and intraoral numbness in a patient with neuro-psychiatric systemic lupus erythematosus: A case report and literature review.
Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.
IFN- γ and TNF- α drive a CXCL10 + CCL2 + macrophage phenotype expanded in severe COVID-19 and other diseases with tissue inflammation.
Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.
Vitamin D status in a monocentric cohort of systemic lupus erythematosus (SLE) patients and correlations with clinical and immunological profile.
Coronary artery bypass graft surgery in a young female with systemic lupus erythematosus and its operative challenges: A case report.
Periocular discoid lupus erythematosus: diagnostic challenges of a clinical and histopathological masquerader.
Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.
Progressive multifocal leukoencephalopathy and sarcoidosis under interleukin 7: The price of healing.
Therapeutic Plasma Exchange Improved Pregnancy-associated Thrombotic Microangiopathy but not the Pregnancy Outcome in Patient with Systemic Lupus Erythematosus.
A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies.
Cardiovascular Considerations of Experimental Hydroxychloroquine Therapy on Patients Diagnosed With COVID-19: A Case Series Review.
Very Late-Onset Systemic Lupus Erythematosus as Unusual Cause of Reversible Functional and Cognitive Impairments in an Octogenarian Patient.
Use of Physician Global Assessment in systemic lupus erythematosus: a systematic review of its psychometric properties.
Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence, significance for clinical presentation and disease outcome.
Potential five-mRNA signature model for the prediction of prognosis in patients with papillary thyroid carcinoma.
Vitiligo-like depigmentation subsequent to subacute cutaneous lupus erythematosus and hydroxychloroquine treatment.
Effects of BAFF neutralization on atherosclerosis associated with systemic lupus erythematosus.
Pickles and warfarin interaction: a case-based review.
Understanding immunopathological fallout of human coronavirus infections including COVID-19: Will they cross the path of rheumatologists?
Children with chronic-refractory autoimmune cytopenias: a single center experience.
MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets.
Influence of total western diet on docosahexaenoic acid suppression of silica-triggered lupus flaring in NZBWF1 mice.
Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations.
Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
Cricoarytenoid joint arthritis: a possible complication of dermatomyositis.
Clinical Features and Outcomes of Bilateral Atypical Femoral Fractures.
An evidence based approach to refractory cutaneous lupus erythematosus.
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
Mechanism of Follicular Helper T Cell Differentiation Regulated by Transcription Factors.
Risk of systemic lupus erythematosus in patients with endometriosis: A nationwide population-based cohort study.
[Proximal myopathy and fulminant heart failure in a 57 year-old female patient with lupus erythematosus].
Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis.
Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.
Response to: ‘Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis’ by Singer et al.
Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus.
[Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma].
Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway.
Ureteric implantation into the bowel portion of augmented bladders during kidney transplantation: a review of urological complications and outcomes.
Activin-A in the regulation of immunity in health and disease.
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development.
Cardiovascular System Affection and Its Relation to First-Year Mortality in Patients Initiating Maintenance Hemodialysis.
Expression Pattern of Telomerase Reverse Transcriptase (hTERT) Variants and Bcl-2 in Peripheral Lymphocytes of Systemic Lupus Erythematosus Patients.
Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.
Acute severe sensory ganglionopathy in systemic lupus erythematous.

Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al.
Response to: ‘Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: ‘Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus’ by Chatzidionysiou et al’ by Bettiol et al.
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
NEW INSIGHTS INTO THE PROGRESSION FROM CUTANEOUS LUPUS TO SYSTEMIC LUPUS ERYTHEMATOSUS.
Outcome of patients with lupus nephritis under long-term immunonephrological care
‘The feeling of not being entitled to something’: fertility, pregnancy, and sexuality among women with systemic lupus erythematosus in South Africa.
Age at diagnosis and health-related quality of life are associated with fatigue in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort.
Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus.
Systemic lupus erythematosus with hypothyroidism as the initial clinical manifestation: A case report.
Urinary biomarkers in lupus nephritis.
The First Case of an Infant with Familial A20 Haploinsufficiency in Korea.
Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn’s disease.
A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics.
Ruptured Mycotic Aneurysm of the Distal Circulation in a Patient with Mucormycosis Without Direct Skull Base Extension: Case Report.
Mechanisms of hypertension in autoimmune rheumatic diseases.
Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day.
Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus.
The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK.
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
Lupus-associated protein losing enteropathy (LUPLE) complicated by a hypercoagulable state and successfully treated with belimumab.
Multiple coronary aneurysms and acute myocardial infarction in a female patient with rhupus: case report and literature review.
Hydroxychloroquine Alternatives for Chronic Disease: Response to a Growing Shortage Amid the Global COVID-19 Pandemic.
Effects of AS2819899, a novel selective PI3Kδ inhibitor, in a NZB/W F1 mouse lupus-like nephritis model.
Metabolic regulation of pathogenic autoimmunity: therapeutic targeting.
Neonatal lupus with left bundle branch block and cardiomyopathy: a case report.
Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus.
A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus
Spontaneous Superior Ophthalmic Vein Thrombosis in a Transgender Man with Systemic Lupus Erythematosus.
[New directions of pharmacotherapy of immune – inflammatory rheumatic diseases].
Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells.
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review.
Kidney outcomes for children with lupus nephritis.
Causes of hospitalization in Systemic Lupus Erythematosus: a narrative review.
Statins in COVID-19: is there any foundation?
MSCs-released TGFβ1 generate CD4+CD25+Foxp3+ in T-reg cells of human SLE PBMC.
Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis.
Outcomes of left ventricular assist device implantation in hypercoagulable patients.
EHR2Vec: Representation Learning of Medical Concepts From Temporal Patterns of Clinical Notes Based on Self-Attention Mechanism.
Autoimmune conditions and primary central nervous system lymphoma risk among older adults.
Genome Variation and Precision Medicine in Systemic Lupus Erythematosus.
Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.
Current Insights in Cutaneous Lupus Erythematosus Immunopathogenesis.
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
Dystrophic Calcinosis Cutis in Systemic Lupus Erythematosus.
Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
Rheumatic immune-related adverse events induced by immune checkpoint inhibitors.
Pulmonary embolism complicated the course of anti-N-methyl-D aspartate receptor encephalitis in a pediatric intensive care unit setting: A case report.
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report.
Effectiveness of Bailing capsules in the treatment of lupus nephritis: A meta‑analysis.
Unexpected macrophage activation syndrome in a healthy young woman: a case report.
Centrally Acting ACE Inhibition in SLE
Comparison of complete renal response and mortality in early- and late-onset lupus nephritis: a multicenter retrospective study of a Japanese cohort.
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.
Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations.
Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants.
Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia.
Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect.
Severe bullous systemic lupus erythematosus successfully treated with low dose rituximab: a case report from sub-Saharan Africa.
Type I interferon antagonists in clinical development for lupus.
Anti-DNA antibodies cross-reactive with β2-glycoprotein I induce monocyte tissue factor through the TLR9 pathway.
Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2/HO-1 pathway.
DNA Vaccination With Hsp70 Protects Against Systemic Lupus Erythematosus in (NZB × NZW)F1 Mice.
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases Part 2.
Bilateral patellar tendon rupture on lupus undergoing corticosteroids: a case report.
Belimumab and Rituximab in Systemic Lupus Erythematosus: A Tale of Two B Cell-Targeting Agents.
A case of severe choroidal detachment in both eyes due to systemic lupus erythematosus.
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
What every nephrologist needs to know about hydroxychloroquine toxicity .
Comparison of treatment response and serious infection of tacrolimus, tacrolimus with mycophenolate mofetil, in comparison to cyclophosphamide as induction treatment for lupus nephritis .
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion.
Prevalence, outcome and prognostic factors of neuropsychiatric systemic lupus erythematosus: A real world single center study.
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
[Atypical hydroxychloroquine maculopathy in an Asian woman with lupus].
Macrophage activation syndrome in a patient with systemic lupus erythematosus.
Prediction of Damage Accrual in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report.
MicroRNA-30e-5p has an Integrated Role in the Regulation of the Innate Immune Response during Virus Infection and Systemic Lupus Erythematosus.
Clinical and histological significance of urinary CD11c+ macrophages in lupus nephritis.
Kidney Biopsy Findings in Patients with COVID-19.
Secondary Renal Neoplasia Following Chemotherapy or Radiation in Pediatric Patients.
Treatment of systemic lupus erythematosus.
Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases.
Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
Bronchoalveolar lavage fluid analysis and mortality risk in systemic lupus erythematosus patients with pneumonia and respiratory failure.
Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
Acquired Human Papilloma Virus Type 6-Associated Epidermodysplasia Verruciformis in a Patient With Systemic Lupus Erythematosus.
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.
Stakeholder-Engaged Derivation of Patient-Informed Value Elements.
Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation.
Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan.
Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al.